Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. - Dormandy,J.A.; Charbonnel,B.; Eckland,D.J. (Lancet, 2005)